Latest debt-to-equity ratio
Arrowhead Pharmaceuticals Debt-to-equity ratio
Direct answer
Arrowhead Pharmaceuticals's debt-to-equity ratio is 295.98%.
The verified market snapshot reports 295.98%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Arrowhead Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 295.98%
Explore related company data
View Arrowhead Pharmaceuticals's market capitalizationView Arrowhead Pharmaceuticals's price-to-book ratioView Arrowhead Pharmaceuticals's return on equityView Arrowhead Pharmaceuticals's dividend yieldView Arrowhead Pharmaceuticals's 52-week price rangeView Arrowhead Pharmaceuticals's revenue growthView Arrowhead Pharmaceuticals's profit marginView all Arrowhead Pharmaceuticals key metricsReturn to Arrowhead Pharmaceuticals profile